Table 3. Periodontal parameters of the subgroups.
Variable | Ch (n=16) | Cg (n=24) | Cp (n=28) | H1h (n=14) | H1g (n=23) | H1p (n=29) | H2h (n=14) | H2g (n=20) | H2p (n=23) |
---|---|---|---|---|---|---|---|---|---|
PI | 1.09 (0.10–2.75) | 1.31a) (0.15–3.00) | 2.07a,b) (0.68–3.00) | 1.17a,c) (0.16–2.58) | 1.51a,c,d) (0.36–2.65) | 1.17a,c,e) (0.30–2.89) | 0.98b,c,d,e,f) (0.21–2.82) | 1.00b,c,d,e,f) (0.18–2.56) | 1.38a,c,g,h) (0.58–2.84) |
GI | 0.54 (0.12–1.67) | 0.67 (0.20–1.45) | 1.12a,b) (0.35–2.58) | 0.56 (0.21–2.43) | 0.92 (0.44–1.57) | 0.91 (0.33–2.21) | 0.83 (0.14–1.28) | 1.08a,b,d,e,f,g) (0.50–2.54) | 1.00 (0.35–2.00) |
PD (mm) | 1.90 (1.00–2.56) | 2.00 (1.12–2.52) | 2.74a,b) (1.10–4.07) | 1.73 (1.00–2.40) | 2.00 (1.10–2.64) | 3.07a,b,d,e) (1.16–7.13) | 2.11 (1.03–2.52) | 2.24a,b,d,e,g) (1.69–3.00) | 2.92a,b,d,e,g) (1.77–3.87) |
BOP% | 7.91 (1.66–9.05) | 32.50a) (15.53–100) | 50.02a,b) (8.38–100) | 9.85b,c) (7.00–9.20) | 33.30a,c,d) (12.82–100) | 52.18a,b,d,e) (3.44–100) | 9.72b,c,e,f) (2.38–9.80) | 38.09a,b,d,e,g) (17.13–66.66) | 91.50a,b,c,d,e,f,g) (0.60–100) |
CAL (mm) | 1.90 (1.00–2.56) | 2.00 (1.12–2.52) | 3.17a,b) (1.16–7.13) | 1.73 (1.00–2.40) | 2.68 (1.10–2.94) | 3.15a,b,d,e) (1.25–4.38) | 1.92 (1.03–2.52) | 2.84a,b,d,e,g) (1.69–4.00) | 3.34a,b,d,e,g) (1.21–4.89) |
Data are shown as median (25%–75%).
Ch: systemically healthy control and gingival health, Cg: systemically healthy control and gingivitis, Cp: systemically healthy control and periodontitis, H1h: hyperlipidemic patients with mild-to-moderate metabolic control and gingival health, H1g: hyperlipidemic patients with mild-to-moderate metabolic control and gingivitis, H1p: hyperlipidemic patients with mild-to-moderate metabolic control and periodontitis, H2h: hyperlipidemic patients with poor metabolic control and gingival health, H2g: hyperlipidemic patients with poor metabolic control and gingivitis, H2p: hyperlipidemic patients with poor metabolic control and periodontitis, PI: plaque index, GI: gingival index, PD: probing pocket depth, BOP: bleeding on probing, CAL: clinical attachment loss.
a)Significant difference from the Ch group (P<0.05); b)Significant difference from the Cg group (P<0.05); c)Significant difference from the Cp group (P<0.05); d)Significant difference from the H1h group (P<0.05); e)Significant difference from the H1g group (P<0.05); f)Significant difference from the H1p group (P<0.05); g)Significant difference from the H2h group (P<0.05); h)Significant difference from the H2g group (P<0.05).